Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482105 · ClinicalTrials.gov registry record · NA
Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells
A NA study, sponsored by University of California, Davis.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00482105 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 7 participants.
The verdict
NCT00482105, a NA study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study is divided into distinct sample collection and analysis phases. In the sample collection phase investigators will tape strip lesions that are designated for biopsy because they are suspected for melanoma. No biopsies will be taken solely in support of this study; rather patients that present lesions that are to be biopsied-in the context of the standard of care-will be enrolled in the study and will have that lesion(s) tape stripped before the biopsy procedure. In the second phase of the study, tape strip samples will be extracted and RNA purified and expression profiled by DNA microarray. The gene expression data will be correlated with histopathology with the expectation that an expression classifier that distinguishes suspect lesions from melanoma can be defined. That classifier will be validated in future studies.
Interventions
- OTHER EGIR Tape
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00482105
The ClinicalTrials.gov registry entry for NCT00482105 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EGIR Tape is the first listed.
NCT00482105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00482105 about?
NCT00482105 is a clinical study titled "Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells". This study is divided into distinct sample collection and analysis phases. In the sample collection phase investigators will tape strip lesions that are designated for biopsy because they are suspected for melanoma. No biopsies will be taken solely in support of this study; rather patients that pres...
What is the current status of trial NCT00482105?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2007-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00482105?
The interventions under investigation include: EGIR Tape (OTHER).
Who is sponsoring clinical trial NCT00482105?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.